Martell Diagnostic Laboratories

Martell Diagnostic Laboratories is a biotechnology startup founded in 2008 with a clear mission to empower women with metastatic breast cancer through real-time monitoring for actionable insights and peace of mind. The company addresses the anxiety of many women living with the concern that their cancer may stop responding to medication or that the disease has advanced before apparent clinical symptoms arise. Their solution lies in a straightforward blood test that can effectively monitor medication response and detect recurrences of HER2 tumors, which is crucial for women with metastatic HER2 tumors. The company received a $365.00K Seed Round investment on 12 June 2018. This investment is pivotal to further the development and deployment of their innovative solution. Although the specific investors for the last investment round are not mentioned, it's clear that Martell Diagnostic Laboratories is gaining traction in the biotechnology sector. With a compelling slogan and a strong value proposition, the company is positioned to make a significant impact in cancer care and contribute to the well-being of patients.